Subpart A. Subpart A—General Provisions

• § 310.3 - Definitions and interpretations.
• § 310.4 - Biologics; products subject to license control.
• § 310.6 - Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.